Trials that use: Odds ratio
New to this method? Read the tutorial →
5,976 results
- Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients: Complete Statistical AnalysisIndependent statistical analysis of Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3): Complete Statistical AnalysisIndependent statistical analysis of Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00988559).
- Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TheresaIndependent statistical analysis of Study to Evaluate VORTX Rx (Theresa): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03741088).
- Thiamine as a Renal Protective Agent in Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Thiamine as a Renal Protective Agent in Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03550794).
- This Is A Study Of Bioavailability And Food Effect For Fesoterodine.: Complete Statistical AnalysisIndependent statistical analysis of This Is A Study Of Bioavailability And Food Effect For Fesoterodine.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- This Is An Open-Label Study To Evaluate Fesoterodine Plus “Your Way” Patient Support Plan In Patients With Symptoms Of Overactive Bladder: Complete Statistical AnalysisIndependent statistical analysis of This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder: primary endpoint results, effect estimate with confidence…
- This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis: Complete Statistical AnalysisIndependent statistical analysis of This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis:…
- This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours): Complete Statistical AnalysisIndependent statistical analysis of This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours): primary endpoint results, effect estimate with…
- This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men: Complete Statistical AnalysisIndependent statistical analysis of This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men: primary endpoint results, effect estimate with…
- This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood: Complete Statistical AnalysisIndependent statistical analysis of This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done…
- Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound: Complete Statistical AnalysisIndependent statistical analysis of Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02218242).
- Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Three Injections of EUFLEXXA (Sodium Hyaluronate) for Treatment of Chronic Shoulder Pain Associated With Osteoarthritis (OA): Complete Statistical AnalysisIndependent statistical analysis of Three Injections of EUFLEXXA (Sodium Hyaluronate) for Treatment of Chronic Shoulder Pain Associated With Osteoarthritis (OA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- THRIVEIndependent statistical analysis of Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- THRIVE Use in Pediatric Populations- Multi Site: Complete Statistical AnalysisIndependent statistical analysis of THRIVE Use in Pediatric Populations- Multi Site: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04322994).
- THUNDER: Acute Ischemic Stroke Study With the Penumbra System® Including Thunderbolt™ Aspiration Tubing: Complete Statistical AnalysisIndependent statistical analysis of THUNDER: Acute Ischemic Stroke Study With the Penumbra System® Including Thunderbolt™ Aspiration Tubing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Thyroid Function of Pediatric Subjects Following Isovue® Administration: Complete Statistical AnalysisIndependent statistical analysis of Thyroid Function of Pediatric Subjects Following Isovue® Administration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03779906).
- TIIndependent statistical analysis of Temporal Interference Brain Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03747601).
- Tibial Delayed Healing Pivotal Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Tibial Delayed Healing Pivotal Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01016067).
- TICL-PASIndependent statistical analysis of STAAR Visian Toric ICL Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04516772).
- TICSIndependent statistical analysis of Tick-borne Illness and Clothing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01454414).
- TICTACIndependent statistical analysis of Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TIDEIndependent statistical analysis of Thiazolidinedione Intervention With Vitamin D Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00879970).
- TIDE-asthmaIndependent statistical analysis of Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243512).
- Timing of Antibiotic Prophylaxis for Cesarean Deliveries: Complete Statistical AnalysisIndependent statistical analysis of Timing of Antibiotic Prophylaxis for Cesarean Deliveries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805545).
- Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms: Complete Statistical AnalysisIndependent statistical analysis of Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TINTINIndependent statistical analysis of Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions: primary endpoint results, effect estimate with confidence interval, sample-size…
- Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial: primary endpoint results, effect estimate with confidence…
- Tipifarnib in Subjects With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib in Subjects With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02779777).
- Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00082888).
- Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients: Complete Statistical AnalysisIndependent statistical analysis of Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00530920).
- TIRCON-EXTIndependent statistical analysis of Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02174848).
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma: primary endpoint results, effect estimate with confidence…
- Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: Complete Statistical AnalysisIndependent statistical analysis of Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TitAINIndependent statistical analysis of A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TITREIndependent statistical analysis of Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00710866).
- TK008Independent statistical analysis of Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TL011 in Severe, Active Rheumatoid Arthritis Patients: Complete Statistical AnalysisIndependent statistical analysis of TL011 in Severe, Active Rheumatoid Arthritis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01123070).
- TMC114IFD3001 – Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV: Complete Statistical AnalysisIndependent statistical analysis of TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company…
- TMH PilotIndependent statistical analysis of Family Telemental Health Intervention for Veterans With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03116464).
- TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04166435).
- TN07Independent statistical analysis of Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women: Complete Statistical AnalysisIndependent statistical analysis of To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer: primary endpoint…
- To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…